Pancreatic Cancer

CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: Pilot Study of Pancreatic Cancer Screening

A pilot study of pancreatic cancer screening led by the University of California, San Francisco is currently recruiting participants.

CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: Iconographic Registry of Pancreatobiliary Endoscopy Procedures

This is a clinical trial registry entry for an endoscopy study in pancreatic diseases that is currently recruiting, listing pancreatic cance…

CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence

A clinical trial update on using artificial intelligence to predict cancer within pancreatic cystic lesions; the study is not yet recruiting…

CLINICAL_TRIALS research · 2025-05-01

Clinical Trial Update: Efficacy of Fistulotomy for Biliary Cannulation [NA]

A clinical trial evaluating the efficacy of fistulotomy for biliary cannulation is currently recruiting in Mexico. It studies patients with …

CLINICAL_TRIALS research · 2025-05-01

Clinical Trial Update: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies [Phase 1, Phase 2]

A Phase 1/2 clinical trial evaluating AMXI-5001 in patients with advanced cancers, including breast, ovarian, prostate, and pancreatic cance…

CLINICAL_TRIALS research · 2025-04-30

Clinical Trial Update: IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer [Phase 1, Phase 2]

A Phase 1/2 clinical trial evaluating IN10018 in combination with KN046 and standard chemotherapy for advanced pancreatic cancer is currentl…

CLINICAL_TRIALS trial_result · 2025-04-29

Clinical Trial Update: Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 [Phase 2]

Phase 2 trial of ponsegromab in cancer patients with cachexia and elevated GDF-15 completed; results posted.

CLINICAL_TRIALS research · 2025-04-29

Clinical Trial Update: A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) [Phase 2]

Phase 2 clinical trial update for Zenocutuzumab (MCLA-128) in solid tumors harboring NRG1 fusions, including non-small cell lung cancer and …

CLINICAL_TRIALS trial_result · 2025-04-29

Clinical Trial Update: A Study of Irinotecan Liposome in Advanced Pancreatic Cancer [Phase 1]

A Phase 1 study of irinotecan liposome in advanced pancreatic cancer has completed.

CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

This update reports the completion of a clinical validation study for Immunovia's VERIFI blood biomarker test intended to detect early-stage…

CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer

This completed clinical trial validates Immunovia's next-generation blood biomarker test for detecting pancreatic cancer at early stages.

CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial [Phase 2]

This ClinicalTrials.gov entry describes a Phase II trial evaluating the safety and effectiveness of hyperthermic intraperitoneal chemotherap…

CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

A clinical trial update on validating a microRNA panel (mirPANC 2) to optimize treatment response in metastatic pancreatic cancer. The study…

CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy [Phase 3]

Phase 3 SENECA trial evaluates first-line metastasis-directed radiotherapy (including primary and distant lesions in oligometastatic pancrea…

CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

A clinical trial update describes using liquid biopsies of circulating tumor cells and circulating tumor DNA to guide precision medicine in …

CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence [NA]

This clinical trial assesses molecular profile-driven, individualized targeted therapy for patients with resected pancreatic cancer at high …

CLINICAL_TRIALS research · 2025-04-25

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]

A2 Biotherapeutics is evaluating A2B530, a logic-gated CAR T therapy, in Phase 1/2 trials for CEA-expressing solid tumors that have lost HLA…

CLINICAL_TRIALS research · 2025-04-25

Clinical Trial Update: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients [Phase 1, Phase 2]

First-in-human Phase 1/2 trial of an autologous dendritic cell vaccine targeting Wilms' tumor protein 1 (WT1) with interleukin-15 trans-pres…

CLINICAL_TRIALS research · 2025-04-25

Clinical Trial Update: A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

This clinical trial outlines a personalized management pathway for locally advanced and borderline resectable pancreatic cancer and is curre…

CLINICAL_TRIALS research · 2025-04-25

Clinical Trial Update: An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer [Phase 2]

An exploratory Phase 2 clinical trial evaluating HRS-4642 in combination with immunotherapy and chemotherapy for pancreatic cancer, currentl…